首页>
外国专利>
Therapeutic approach designed to treat with a combination of anti-CD19 antibody and venetoclax
Therapeutic approach designed to treat with a combination of anti-CD19 antibody and venetoclax
展开▼
机译:旨在用抗CD19抗体和嘌呤菌的组合治疗治疗方法
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present disclosure provides anti-CD19 antibodies and venetoclax for use in the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia and/or small lymphocytic lymphoma. The anti-CD19 antibodies, in particular MOR00208, and venetoclax are administered to patients suffering non-Hodgkin's lymphoma (NHL), chronic lymphocytic leukemia (CLL) and/or small lymphocytic lymphoma (SLL) according to a specific treatment paradigm to mitigate therapy associated tumor lysis syndrome.
展开▼